|
|
|
|
|
|
|
|
|
|
| (a) Age |
|
|
|
| (1) 55-59 |
17 |
|
|
| (2) 60-64 |
16 |
|
|
| (3) 65-69 |
22 |
|
|
| (4) 70-74 |
44 |
|
|
| (5) 75-79 |
68 |
|
|
| (6) 80-84 |
77 |
|
|
| (7) 85 and over |
105 |
|
|
|
|
|
|
| (b) Gender |
|
|
|
(a) Female
|
265
|
|
|
(b) Male
|
106
|
|
|
|
|
|
|
| (c) Race/ethnicity |
|
|
|
| (1) White (non-Hispanic) |
337 |
|
| (2) Black (non-Hispanic) |
1 |
|
|
| (3) American Indian or Alaskan Native |
17 |
|
|
| (4) Asian or Pacific Islander |
1 |
|
|
| (5) Hispanic |
8 |
|
|
| (6) Not Reported |
7 |
|
|
|
|
|
|
| (d) Visual Disability |
|
|
|
| (1) Totally Blind (LP only or NLP) |
6 |
|
|
| (2) Legally blind (excluding total blindness) |
149 |
|
|
| (3) Severe visual impairment |
190 |
|
|
|
|
|
|
| (e) Non-Visual Disabilities (as reported by the individual) |
|
|
|
| (1) Alterations in mental functioning |
2 |
|
|
| (2) Cancer |
2 |
|
|
| (3) Cardiovascular disease |
29 |
|
|
| (4) Deaf or hard-of-hearing |
18 |
|
|
| (5) Diabetes (Type I & II) |
39 |
|
|
| (6) Kidney failure |
0 |
|
|
| (7) Musculoskeletal |
3 |
|
|
| (8) Neurologic changes due to: stroke, diabetes, other. |
41 |
|
|
| (9) Respiratory or lung conditions |
0 |
|
|
| (10) Other |
0 |
|
|
|
|
|
|
|
|
|
|
